Companies: 10,795·Total market cap: $144.5T
NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSNNASDAQHealthcare● Active
$0.75
+$0.00(+0.20%)
Market Cap$18539466
P/E Ratio
52W High$2.6
52W Low$0.63
Overview

NeuroSense Therapeutics Ltd.(NRSN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

nrsn · 股价预测 · 2 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.75

NeuroSense Therapeutics Ltd.(NRSN)的分析师共识为 Buy,基于过去 3 个月内 2 位华尔街分析师的评级。NRSN 的 12 个月平均目标价为 $0.00,相对当前价 $0.75 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.733.37%

1-day model range: $0.72–$0.73. Peak: $0.73 (-3.37%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$0-38.9%
2028$0-50.7%
2029$0-55.5%
2030$0-57.7%
2031-58.7%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)47.4Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NRSN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.77SELL
MA 10$0.81SELL
MA 20$0.81SELL
MA 50$0.79SELL
MA 100$0.84SELL
MA 200$0.96SELL
Current $NRSN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.77SELL
EMA 10$0.79SELL
EMA 20$0.80SELL
EMA 50$0.81SELL
EMA 100$0.85SELL
EMA 200$0.96SELL
Current $NRSN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
D. Boral Capital2026-04-08
Maintains
BuyBuy
D. Boral Capital2026-03-25
Maintains
BuyBuy
D. Boral Capital2026-03-17
Maintains
BuyBuy
D. Boral Capital2026-03-09
Maintains
BuyBuy
D. Boral Capital2025-12-22
Maintains
BuyBuy
D. Boral Capital2025-11-24
Maintains
BuyBuy
D. Boral Capital2025-08-15
Maintains
BuyBuy
D. Boral Capital2025-07-10
Maintains
BuyBuy
Maxim Group2024-12-16
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on NeuroSense Therapeutics Ltd. (NRSN) stock. Of the recent 9 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover NRSN.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

NRSN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$1M

↓ 94.7% YoY

Revenue Next Year

$3M

↑ 359.0% YoY

EPS This Year

$-0.39

EPS Next Year

$-0.82

↑ 113.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NRSN EPS of $-0.39 for the current fiscal year, based on estimates from 1 analysts. The NRSN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

NRSN 股价预测由两类独立数据源支撑:来自 2 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。NRSN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

NRSN 的短期预测(明日)为 $0.73(-3.37%)。 NRSN 对 2027 年的股价预测均值为 $0。 NRSN 对 2030 年的预测区间为 $0–$0。

NeuroSense Therapeutics Ltd. 在 NASDAQ 上市,代码 NRSN。NRSN 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

NRSN 预测 · 8 个问题

根据 2 位华尔街分析师,NRSN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $0.75,隐含约 +0.0% 的上行空间。

NRSN 目标价NRSN 分析师目标价NRSN 12个月目标价目标价 NRSN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.